PL3004891T3 - Biomarker ponownej hospitalizacji po niewydolności serca - Google Patents

Biomarker ponownej hospitalizacji po niewydolności serca

Info

Publication number
PL3004891T3
PL3004891T3 PL14728216T PL14728216T PL3004891T3 PL 3004891 T3 PL3004891 T3 PL 3004891T3 PL 14728216 T PL14728216 T PL 14728216T PL 14728216 T PL14728216 T PL 14728216T PL 3004891 T3 PL3004891 T3 PL 3004891T3
Authority
PL
Poland
Prior art keywords
rehospitalization
biomarker
heart failure
heart
failure
Prior art date
Application number
PL14728216T
Other languages
English (en)
Inventor
Philippe Rouet
Fatima SMITH-ROUET
Franck Desmoulin
Michel Galinier
Original Assignee
INSERM (Institut National de la Santé et de la Recherche Médicale)
Université Paul Sabatier Toulouse Iii
Centre Hospitalier Universitaire De Toulouse
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INSERM (Institut National de la Santé et de la Recherche Médicale), Université Paul Sabatier Toulouse Iii, Centre Hospitalier Universitaire De Toulouse filed Critical INSERM (Institut National de la Santé et de la Recherche Médicale)
Publication of PL3004891T3 publication Critical patent/PL3004891T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4703Regulators; Modulating activity
    • G01N2333/4704Inhibitors; Supressors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4745Insulin-like growth factor binding protein
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • G01N2800/325Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/56Staging of a disease; Further complications associated with the disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL14728216T 2013-06-06 2014-06-06 Biomarker ponownej hospitalizacji po niewydolności serca PL3004891T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13305760 2013-06-06
EP14728216.4A EP3004891B1 (en) 2013-06-06 2014-06-06 Biomarker of rehospitalization after heart failure
PCT/EP2014/061819 WO2014195456A1 (en) 2013-06-06 2014-06-06 Biomarker of rehospitalization after heart failure

Publications (1)

Publication Number Publication Date
PL3004891T3 true PL3004891T3 (pl) 2019-09-30

Family

ID=48651943

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14728216T PL3004891T3 (pl) 2013-06-06 2014-06-06 Biomarker ponownej hospitalizacji po niewydolności serca

Country Status (16)

Country Link
US (1) US11112414B2 (pl)
EP (1) EP3004891B1 (pl)
JP (1) JP6480427B2 (pl)
CY (1) CY1121748T1 (pl)
DK (1) DK3004891T3 (pl)
ES (1) ES2725906T3 (pl)
HR (1) HRP20190801T1 (pl)
HU (1) HUE043373T2 (pl)
LT (1) LT3004891T (pl)
PL (1) PL3004891T3 (pl)
PT (1) PT3004891T (pl)
RS (1) RS58694B1 (pl)
SI (1) SI3004891T1 (pl)
SM (1) SMT201900258T1 (pl)
TR (1) TR201906948T4 (pl)
WO (1) WO2014195456A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3213079A2 (en) * 2014-10-28 2017-09-06 Wisconsin Alumini Research Foundation Biomarkers for early diagnosis and differentiation of mycobacterial infection
EP4056585A4 (en) * 2019-11-06 2024-03-13 National University Corporation Kagawa University HEART FAILURE MARKER

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6066464A (en) * 1996-12-10 2000-05-23 Diagnostic Systems Laboratories, Inc. Immunoassay of IGF family of peptides, their binding proteins and related molecules in dried whole blood filter paper spots
US20060172429A1 (en) 2005-01-31 2006-08-03 Nilsson Erik J Methods of identification of biomarkers with mass spectrometry techniques
JP5399900B2 (ja) * 2006-06-30 2014-01-29 メルク・シャープ・アンド・ドーム・コーポレーション Igfbp2インヒビター
JP2010517023A (ja) * 2007-01-25 2010-05-20 エフ.ホフマン−ラ ロシュ アーゲー 心不全の評価におけるigfbp−7の使用
EP2841945A4 (en) * 2012-04-24 2016-04-27 Astute Medical Inc METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING OF STROKE OR OTHER BRAINS
WO2014023820A1 (en) 2012-08-09 2014-02-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Diagnostic of heart failure
WO2014116708A1 (en) * 2013-01-22 2014-07-31 Singulex, Inc. Endothelin in the diagnosis of cardiac disease

Also Published As

Publication number Publication date
DK3004891T3 (da) 2019-05-20
HRP20190801T1 (hr) 2019-08-09
LT3004891T (lt) 2019-07-25
EP3004891A1 (en) 2016-04-13
US20160123995A1 (en) 2016-05-05
JP6480427B2 (ja) 2019-03-13
TR201906948T4 (tr) 2019-06-21
CY1121748T1 (el) 2020-07-31
RS58694B1 (sr) 2019-06-28
WO2014195456A1 (en) 2014-12-11
HUE043373T2 (hu) 2019-08-28
ES2725906T3 (es) 2019-09-30
PT3004891T (pt) 2019-05-30
JP2016520843A (ja) 2016-07-14
SI3004891T1 (sl) 2019-08-30
SMT201900258T1 (it) 2019-07-11
US11112414B2 (en) 2021-09-07
EP3004891B1 (en) 2019-02-20

Similar Documents

Publication Publication Date Title
GB201307195D0 (en) Balcony
GB201211982D0 (en) Biomarker
GB201321474D0 (en) Novel biomarkers
GB201318793D0 (en) Vascular Biomarkers
GB201316524D0 (en) Biomarkers
SG11201510029UA (en) Improved ngs workflow
GB201309426D0 (en) Biomarkers
GB201316526D0 (en) Biomarkers
GB201308077D0 (en) Biomarkers
PT3051152T (pt) Estrutura de ligação para peças de madeira
GB201304460D0 (en) Biomarker
GB201312638D0 (en) Biomarkers
GB201310730D0 (en) New structure
PL3004891T3 (pl) Biomarker ponownej hospitalizacji po niewydolności serca
GB201316131D0 (en) Biomarkers for disease stratification
GB201209802D0 (en) Biomarker
GB201202944D0 (en) Biomarker
EP3069146A4 (en) Biomarker for cardiac disorders
GB201308518D0 (en) Novel Biomarker
GB201322783D0 (en) Biomarkers
TWM475821U (en) Structure of mosquito-catch
GB201313342D0 (en) Biomarkers
GB201204391D0 (en) Biomarker
GB201200507D0 (en) Biomarker
GB201320032D0 (en) Novel methods for increasing heart contractility and preventing heart failure